Population-based evidence for the preventative efficacy of quadrivalent HPV in Australia

The HPV vaccination programmes introduced by many countries over the last few years (since 2007) reveal considerable diversity in the coverage they have achieved, the mode of access (i.e. school, public health, private clinics) and responsibility for cost (i.e. publically vv. privately funded) – even in Europe (see ECDC Guidance).  In the light of the […]

Read More…

Pre-test HIV risk reduction counselling is not worth the money

A large US randomized control trial of the impact on STI risk of HIV risk reduction counselling in conjunction with the HIV test (Metsch & Colfax) challenges the view that pre-test counselling constitutes an efficient use of limited resources – at least in the US setting. Counselling has long had an important place in the […]

Read More…

UNAIDS assesses progress towards #HIV Millennium Development Goal

In the run-up to the 2013 General Assembly of the UN in New York, a new report from the Joint United National Program on HIV/AIDS seeks to give an overview of progress to date towards Millenium Goal 6 – the goal of halting and beginning to reverse the HIV/AIDS epidemic by 2015 (UNAIDS Report 2013). […]

Read More…

Should ART provision be decentralized to health centres in low and middle income countries?

With the realization of the value of ART as a means of preventing HIV transmission, the question of how best to retain HIV-diagnosed in care becomes all the more pressing.  Recent STI blogs have covered such topics as the potential role of computer-generated reminders in retaining patients (sti blogs03/05/13), as well as the re-engagement of […]

Read More…

Social Enterprise for Sexual Health (SESH): a new model for service provision?

Have you heard of SESH – social enterprise for sexual health?  It holds the answer to many of the problems that the dominant model, based on centralized public clinic service delivery has failed to resolve, according to Tucker, Fenton et al. in this month’s PLoS – Medicine.  The paper acclaims an alternative approach focussing on […]

Read More…

The dapivirine ring: success at last for a vaginal microbicide?

The International Partnership for Microbicides (IPM) has just announced the launch of a trial (IPM 027) to evaluate the effectiveness of the antiretroviral (ARV) drug dapivirine delivered by means of a monthly replaceable vaginal ring (http://www.ipmglobal.org/node/670).  The IPM study, which has enrolled 1,650 women at four sites in South Africa, is part of a broader […]

Read More…

Could Millennium Development Goals be bad for your health?

A recent paper by a Belgian team discusses the health impact of the Millennium Development Goals (MDG) in sub-Saharan Africa, and highlights the potential short-termism of a strategic approach focussed on “quick wins”.  Many of the health issues discussed touch on sexual health. The year 2001 saw poverty become the focus of the global political […]

Read More…

Non-targeted HIV testing in health settings – worthwhile?

A large, recently published French study, based in metropolitan Paris, places a question mark over the value of non-targeted HIV screening as a strategy to lower the number of undiagnosed infections and improve early detection. Late diagnosis of HIV remains a common problem both in France – where, despite accessible testing, one-third of diagnoses are […]

Read More…

First ever WHO guidelines on HIV prevention and treatment for MSM and TG

The World Health Organization (WHO) has issued its first ever guidelines on the prevention and treatment of HIV for populations of men who have sex with men (MSM) and transgender individuals (TG). The guidelines have been in preparation since the September 2008 WHO global consultation in Geneva. Both populations – MSM and TG – are […]

Read More…

The right way forward for global HIV/AIDS response?

Almost thirty years exactly after the first official AIDS diagnosis on 1st June 1981, and 10 years since the landmark UN General Assembly Special Session on HIV/AIDS, member countries meet once again to review the global response to HIV AIDS at the UN General Assembly High-Level Meeting on HIV/ AIDS from 8–10 June in New […]

Read More…